Swollen upper limb with synthetic Arteriovenous graft

Vascular Access Complication

Arterioarterial synthetic graft

Mansoura University

Arterio-arterial Vascular Access as a Novel Technique for Treatment of Venous Hypertention With Arterio-venous Vascular Access

Duplex ultrasound assessment of the patency

Continue haemodialysis of the access for 4 hours

Patients will be randomized (by block randomization) to Desferal (DFO) treatment.

Patients will be randomized (by block randomization) to isotonic saline treatment.

Diabetes Mellitus, Type 1

It is a blinded randomized cross-over study that investigates the efficacy of DFO (50mg/kg) given i.v before intermittent hypoxia (IH) to improve the cardiorespiratory and angiogenetic response in patients with diabetes.

desferal

It is a blinded randomized cross-over study that investigates the efficacy of isotonic saline given i.v before intermittent hypoxia (IH) to improve the cardiorespiratory and angiogenetic response in patients with diabetes.

Isotonic saline

Karolinska University Hospital

Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes

The absolute amount of endothelial precursor cells in 10 ml of blood

Sergiu Catrina

Senior consultant / associated professor

This is a randomised, double-blind, placebo-controlled, cross-over, single center study of patients with diabetes mellitus type 1 without chronic complications.

Dipeptidyl-peptidase-4

STEMI

No-reflow

Bleeding

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

TIMI flow grade of <3 with a myocardial blush grade of 0-1 was defined as angiographic no-reflow

the composite of death, nonfatal MI, or stroke

defined as acute heart failure, atrial fibrillation, chest pain or re-acute myocardial infarction, complete atrioventricular block, cerebrovascular disease, ventricular fibrillation or ventricular tachycardia

defined as absolute hemoglobin drop (baseline to nadir)≥4g/dl, intracranial hemorrhage, retroperitoneal hemorrhage, use of red blood cell transfusion in patients with a baseline hemoglobin ≥9.0 g/dl, and use of red blood cell transfusion among patients with a baseline hemoglobin <9.0 g/dl and a witnessed bleeding event

ischemia/proliini

Arterio-arterial Vascular Access as a Novel Technique for Treatment of Venous Hypertention With Arterio-venous Vascular Access

Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

Täydellisin lääketieteellinen tietokanta tieteen tukemana